» Articles » PMID: 21787999

HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies This Document Was Developed As a Partnership Between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

Citing Articles

Sudden Cardiac Death: The Role of Molecular Autopsy with Next-Generation Sequencing.

Fadoni J, Santos A, Amorim A, Caine L Diagnostics (Basel). 2025; 15(4).

PMID: 40002611 PMC: 11854515. DOI: 10.3390/diagnostics15040460.


Genetic Background and Clinical Phenotype in an Italian Cohort with Inherited Arrhythmia Syndromes and Arrhythmogenic Cardiomyopathy (ACM): A Whole-Exome Sequencing Study.

dApolito M, Santoro F, Ranaldi A, Cannito S, Santacroce R, Ragnatela I Int J Mol Sci. 2025; 26(3).

PMID: 39940965 PMC: 11818934. DOI: 10.3390/ijms26031200.


The impact of common and rare genetic variants on bradyarrhythmia development.

Weng L, Ramo J, Jurgens S, Khurshid S, Chaffin M, Hall A Nat Genet. 2025; 57(1):53-64.

PMID: 39747593 PMC: 11735381. DOI: 10.1038/s41588-024-01978-2.


Exploratory DNA methylation analysis in post-mortem heart tissue of sudden unexplained death.

Sutter C, Haas C, Bode P, Neubauer J, Dyrberg Andersen J Clin Epigenetics. 2024; 16(1):167.

PMID: 39578896 PMC: 11585171. DOI: 10.1186/s13148-024-01777-w.


Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.